Hologic Inc (HOLX)

Cash ratio

Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Cash and cash equivalents US$ in thousands 1,735,200 1,429,500 1,782,100 2,160,200 2,439,100 2,180,000 1,932,100 2,722,500 2,765,000 2,582,200 2,441,300 2,339,500 2,375,300 2,290,800 1,420,800 1,170,300 827,600 816,400 868,700 701,000
Short-term investments US$ in thousands 143,900 191,500 190,600 173,400 8,500 7,900 22,000 16,200 24,000 27,100 35,100 31,900 19,000 5,500
Total current liabilities US$ in thousands 962,500 989,700 1,002,400 1,037,200 1,002,400 954,600 899,000 1,207,300 981,300 955,000 956,200 937,700 1,000,900 1,305,100 1,278,700 1,326,800 1,464,600 1,036,400 1,056,000 1,239,300
Cash ratio 1.95 1.64 1.97 2.25 2.44 2.29 2.17 2.27 2.84 2.73 2.59 2.53 2.39 1.76 1.11 0.88 0.57 0.79 0.82 0.57

June 30, 2025 calculation

Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($1,735,200K + $143,900K) ÷ $962,500K
= 1.95


Peer comparison

Jun 30, 2025

Company name
Symbol
Cash ratio
Hologic Inc
HOLX
1.95
Becton Dickinson and Company
BDX
0.10